RDY News and Press, Dr. Reddy's Laboratories Ltd From 09/25/25

2025-09-25 11:42:45 ET Just over four months have passed since the publication of my last article , "Why Investors Should Watch Teva Despite Regional Risks," and during that time, the Teva Pharmaceutical Industries Limited (TEVA) share price has risen by 14%.... Read the full ...

Coya Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) PR Newswire FDA acceptance enables initiation of a Phase 2 multicenter, double-blind, placebo-controlled clinical stud...

2025-08-07 13:00:58 ET More on Merck, Eli Lilly, etc. Perrigo Company plc 2025 Q2 - Results - Earnings Call Presentation Perrigo Company plc (PRGO) Q2 2025 Earnings Call Transcript Amneal Pharmaceuticals, Inc. 2025 Q2 - Results - Earnings Call Presentation Ca...

2025-08-04 15:48:08 ET More on Infosys, Wipro, etc. Wall Street Lunch: Tesla Approves 96 Million Shares Award To Musk Dr. Reddy's: Needs To Invest $0.95 To Produce $1 Of New Revenues Apple: A $500 Billion Problem Tech Voices: Baidu-Lyft robotaxis, Spotify, Mu...

2025-08-04 06:10:00 ET Investment Summary Dr. Reddy’s Laboratories ( RDY ) entered FY '26 well positioned and posted reasonable Q1 FY'26 numbers in July. Since my last publication, the stock has been heavily sold and remains in a cyclical downtrend on the ...

Dr. Reddy's Laboratories Ltd (RDY) is expected to report $0.18 for Q1 2026

2025-07-23 18:09:27 ET Dr. Reddy's Laboratories Limited (RDY) Q1 2026 Earnings Conference Call July 23 2025, 10:00 AM ET Company Participants Erez Israeli - CEO & Member of the Management Council Mannam Venkatanarasimham - CFO & Member of the Management Counc...

2025-07-23 13:49:37 ET Listen below or on the go on Apple Podcasts and Spotify A new batch of stocks are seeing meme-like action and retail interest. (0:15) AT&T tops estimates . (1:37) Fiserv slumps . (2:04)... Read the full article on Seek...

Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY) today announced its consolidated financial results for the quarter ended June 30, 2025. The information mentioned in this release is based on consolidated financial statements under International Fina...

2025-07-23 10:43:55 ET More on Dr. Reddy's, Novo Nordisk Novo Nordisk: The Market Hasn't Given It Enough Respect Novo Nordisk's Moat Is Deeper Than You Think Novo Nordisk Has So Much Room To Go Novo Nordisk owner partners with Denmark to acquire Microsoft's q...